A study carried out by a team of researchers from The Institute of Cancer Research, London, found that combining two types of ...
As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...
It is hoped it will allow medics to better understand how cancer cells are behaving before planning treatment.
A combination of genetic tests for a "very complex" blood cancer could accurately predict if the disease is likely to return ...
Scientists have identified a more accurate way of predicting which patients with multiple myeloma are likely to relapse early ...
The U.S. Food and Drug Administration (FDA) has updated the safety labeling for Carvykti, the multiple myeloma therapy ...
Iberdomide combined with standard therapies showed a statistically significant improvement in minimal residual disease (MRD) negativity rates, compared with the control arm, in patients with relapsed ...
Scientists discovered that inhibiting the enzyme STK17B forces multiple myeloma cells into iron-driven death and makes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback